Policy Implementation Analysis:
Health Affairs Blog — The Write Track, Inc.
Michael D. Dalzell/Editing Samples
Biologic therapies are a fast-growing concern for managed care payers, employer purchasers, and government policy makers. This 2017 case study, published on the Health Affairs blog, describes how a managed care organization and a biologic-drug manufacturer with seemingly diverse interests came together in a spirit of cooperation and accountability to forge a new model for doing business. This article describes how they succeeded — even as each faced unique challenges in implementing this agreement.
DOWNLOAD FULL PAPER FROM HEALTHAFFAIRS.ORG
Policy Implementation Analysis: Health Affairs Blog
4/3/17
THE CHALLENGE:
Managed care payers and manufacturers of biologic drugs are often perceived as having misaligned interests. But when good patient care becomes the focus of all involved, solutions follow. Both of the parties in this piece persevered through one obstacle after another to execute a pilot outcomes-based contract for a cancer therapy. In editing this essay, I worked with the authors to make it succinct, prevent it from becoming a litany of travails, and to keep the story flowing toward an honest and positive reflection about lessons learned.
